Advances in genetics, the implementation of newborn screening (NBS), and the availability of sweat tests allow for early diagnosis of children with cystic fibrosis (CF) and CFTR-related metabolic syndrome (CRMS) in the United States of America. The gene discussed is CFTR; the disease is CFTR-related metabolic syndrome/CF screen positive, inconclusive diagnosis.